Shanghai, China

Fanhong Wu

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fanhong Wu: Innovator in Pharmaceutical Chemistry

Introduction

Fanhong Wu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug derivatives. His work focuses on creating compounds that can effectively treat various diseases, including cancer.

Latest Patents

Fanhong Wu holds 2 patents that showcase his expertise in drug development. One of his latest patents is related to 5-fluorouracil derivatives, which are designed for the treatment of cancer and tumor diseases. This patent discloses a derivative with a specific molecular structure that includes various alkoxy groups and linking groups, aimed at enhancing the efficacy of cancer treatment. Another significant patent involves ethoxy diphenyl ethane derivatives, which are modified to create water-soluble prodrugs. These compounds exhibit strong tubulin aggregation inhibition and target tumor vessels, thereby inducing apoptosis in vascular endothelial cells and inhibiting tumor metastasis.

Career Highlights

Throughout his career, Fanhong Wu has worked with various companies, including Shanghai Ecust Biomedicine Co., Ltd. His innovative approaches and dedication to research have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Fanhong Wu has collaborated with notable colleagues such as Jinwen Huang and Jiujiu Zhou. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Fanhong Wu's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to improving cancer treatment. His work continues to influence the field and offers hope for better therapeutic options in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…